Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00305838
Status:
UNKNOWN
Last Update Posted:
2013-08-12
First Post:
2006-03-21
Brief Title:
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Sponsor:
Mount Vernon Cancer Centre at Mount Vernon Hospital
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000463518
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mount Vernon Cancer Centre at Mount Vernon Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None